Skip to search.
 TSX Down 0.67% TSX Ventures Up 0.03%

Nektar Therapeutics (NKTR)

-NasdaqGS
18.75 Down 0.77(3.94%) Sep 23, 4:00PM EDT
Prev Close:19.52
Open:19.50
Bid:8.09 x 100
Ask:N/A
1y Target Est:19.33
Beta:1.61777
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:18.58 - 19.50
52wk Range:9.92 - 19.98
Volume:1,288,238
Avg Vol (3m):1,058,150
Market Cap:2.56B
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NKTRDown 3.94%2.56B
GSKDown 0.37%105.53B
ENZNDown 2.37%16.27M
BMYUp 0.11%94.37B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.11
Quarterly EPS Est (Sep-16) :-0.35
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):2.41

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback